Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10598-10604

  Jonges, Marcel ^a,b   Bataille, Arnaud ^c,d   Enserink, Remko ^a   Meijer, Adam ^a   Fouchier, Ron A M ^b   Stegeman, Arjan ^c   Koch, Guus ^d   Koopmans, Marion ^a,b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; PROTEIN PB2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS SIALIDASE;

AMINO ACID SEQUENCE; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CLINICAL ARTICLE; COMPARATIVE STUDY; EVOLUTIONARY ADAPTATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS A H7N7; HUMAN; MUTANT; NONHUMAN; POULTRY; PRIORITY JOURNAL; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MUTATION, MISSENSE; NETHERLANDS; NEURAMINIDASE; POULTRY; RNA REPLICASE; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 80054986522     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05369-11     Document Type: Article

References (51)

1. Bataille, A., F. van der Meer, A. Stegeman, and G. Koch. 2011. Evolutionary analysis of inter-farm transmission dynamics in a highly pathogenic avian influenza epidemic. PLoS Pathog. 7:e1002094.
2. Beare, A. S., and R. G. Webster. 1991. Replication of avian influenza viruses in humans. Arch. Virol. 119:37-42.
3. Belser, J. A., D. A. Wadford, J. Xu, J. M. Katz, and T. M. Tumpey. 2009. Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract. J. Virol. 83:7075-7084.
4. Bitko, V., A. Musiyenko, and S. Barik. 2007. Viral infection of the lungs through the eye. J. Virol. 81:783-790.
5. Bos, M. E., et al. 2009. Back-calculation method shows that within-flock transmission of highly pathogenic avian influenza (H7N7) virus in the Netherlands is not influenced by housing risk factors. Prev. Vet. Med. 88:278-285.
6. Bos, M. E., et al. 2007. Estimating the day of highly pathogenic avian influenza (H7N7) virus introduction into a poultry flock based on mortality data. Vet. Res. 38:493-504.
7. Butt, K. M., et al. 2005. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. 43:5760-5767.
8. Capua, I., and D. J. Alexander. 2004. Avian influenza: recent developments. Avian Pathol. 33:393-404.
9. Capua, I., et al. 2002. The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications. Acta Trop. 83:7-11.
10. Centers for Disease Control and Prevention. 2004. Update: influenza activity- United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 53:547-552.
11. Chen, G. W., et al. 2006. Genomic signatures of human versus avian influenza A viruses. Emerg. Infect. Dis. 12:1353-1360.
12. de Jong, M. D., et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207.
13. de Wit, E., et al. 2010. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 84:1597-1606.
14. Du Ry van Beest Holle, M., A. Meijer, M. Koopmans, and C. M. de Jager. 2005. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Euro Surveill. 10:264-268.
15. Eames, K. T., et al. Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales. BMC Infect. Dis. 10:141.
16. Finkelstein, D. B., et al. 2007. Persistent host markers in pandemic and H5N1 influenza viruses. J. Virol. 81:10292-10299.
17. Fitch, W. M. 1971. Toward Defining the Course of Evolution: Minimum Change for a Specific Tree Topology. Syst. Zoology 20:406-416.
18. Fouchier, R. A., et al. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361.
19. Gabriel, G., et al. 2005. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl. Acad. Sci. U. S. A. 102:18590-18595.
20. Guo, Y., J. Li, and X. Cheng. 1999. Discovery of men infected by avian influenza A (H9N2) virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 13:105-108. (In Chinese.)
21. Hirst, M., et al. 2004. Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg. Infect. Dis. 10:2192-2195.
22. Iglesias, I., M. Martinez, M. J. Munoz, A. De La Torre, and J. M. Sanchez-Vizcaino. 2010. First case of highly pathogenic avian influenza in poultry in Spain. Transbound. Emerg. Dis. 57:282-285.
23. Jonges, M., et al. 2010. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J. Clin. Microbiol. 48:928-940.
24. Jonges, M., et al. 2009. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res. 83:290-297.
25. Kolaczkowski, B., and J. W. Thornton. 2004. Performance of maximum parsimony and likelihood phylogenetics when evolution is heterogeneous. Nature 431:980-984.
26. Koopmans, M., et al. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593.
27. Li, Z., et al. 2005. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 79:12058-12064.
28. Miotto, O., A. Heiny, T. W. Tan, J. T. August, and V. Brusic. 2008. Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis. BMC Bioinformatics 9(Suppl. 1):S18.
29. Miotto, O., et al. 2010. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 5:e9025.
30. Naffakh, N., P. Massin, N. Escriou, B. Crescenzo-Chaigne, and S. van der Werf. 2000. Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. J. Gen. Virol. 81:1283-1291.
31. Neumann, G., and Y. Kawaoka. 2006. Host range restriction and pathogenicity in the context of influenza pandemic. Emerg. Infect. Dis. 12:881-886.
32. Nguyen-Van-Tam, J. S., et al. 2006. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 11:E060504.2.
33. Palese, P. 2004. Influenza: old and new threats. Nat. Med. 10:S82-S87.
34. Parrish, C. R., et al. 2008. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72:457-470.
35. Peiris, M., W. C. Yam, K. H. Chan, P. Ghose, and K. F. Shortridge. 1999. Influenza A H9N2: aspects of laboratory diagnosis. J. Clin. Microbiol. 37: 3426-3427.
36. Pond, S. L., and S. D. Frost. 2005. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21:2531-2533.
37. Potier, M., L. Mameli, M. Belisle, L. Dallaire, and S. B. Melancon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
38. Pouseele, H., P. Vauterin, and L. Vauterin. 2011. A resampling strategy for reliable network construction. Mol. Phylogenet. Evol. 60:273-286.
39. Rabinowitz, P., M. Perdue, and E. Mumford. 2010. Contact variables for exposure to avian influenza H5N1 virus at the human-animal interface. Zoonoses Public Health 57:227-238.
40. Rojas, H., R. Moreira, P. Avalos, I. Capua, and S. Marangon. 2002. Avian influenza in poultry in Chile. Vet. Rec. 151:188.
41. Shi, H. Y., and X. F. Liu. 2006. Molecular mechanism affecting route of transmission for H9N2 subtype AIV. Wei Sheng Wu Xue Bao 46:48-54. (In Chinese.)
42. Sokal, R. R., and F. J. Rohlf. 1962. The comparison of dendrograms by objective methods. Taxon 11:33-40.
43. Sorrell, E. M., H. Song, L. Pena, and D. R. Perez. 2010. A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J. Virol. 84:11831-11840.
44. Steel, J., A. C. Lowen, S. Mubareka, and P. Palese. 2009. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5:e1000252.
45. Stevens, J., et al. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
46. Tweed, S. A., et al. 2004. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis. 10:2196-2199.
47. van den Berg, T., and P. Houdart. 2008. Avian influenza outbreak management: action at time of confirmation, depopulation and disposal methods; the 'Belgian experience' during the H7N7 highly pathogenic avian influenza epidemic in 2003. Zoonoses Public Health 55:54-64.
48. Wan, H., and D. R. Perez. 2007. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J. Virol. 81:5181-5191.
49. Webby, R., E. Hoffmann, and R. Webster. 2004. Molecular constraints to interspecies transmission of viral pathogens. Nat. Med. 10:S77-S81.
50. World Health Organization. 2004. Avian influenza virus A (H10N7) circulating among humans in Egypt. EID weekly updates: emerging and reemerging infectious diseases, region of the Americas, vol. 2. World Health Organization, Geneva, Switzerland.
51. World Health Organization. 2011. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO, confirmed human cases of avian influenza A(H5N1). World Health Organization, Geneva, Switzerland.